Mental Health Research Group
Research group
Group Leader
Víctor Pérez Solà
The Mental Health Research Group is a multidisciplinary team made up of different mental health professionals, experts in neuroimaging, technicians and research support personnel. The group’s main lines of research are:
• Affective disorders: new therapeutic instruments with greater resistance in depression; suicide prevention; structural and functional neuroimaging; biological and genetic markers; identification and assessment of new therapeutic targets and programmes; pharmacogenetics.
• Psychotic disorders: environmental, biological and genetic factors; efficacy and effectiveness of antipsychotic drugs; first psychotic episodes, genotype-environment and phenotype-environment interactions; neuroimaging; pharmacogenetics; new therapeutic strategies.
• Therapeutics in mental health: treatment efficacy and resistance; validation of diagnostic and assessment scales; systematic check-ups; neuropsychology; neurophysiology; neuroimaging.
Members
Pilar Álvarez López (Researcher)
Maria Teresa Campillo Sanz (Researcher)
Francesc Colom Victoriano (Researcher)
Marc Grifell Guàrdia (Researcher)
Ana Moreno Alcázar (Researcher)
Antonio Luis Palomo Nicolau (Researcher)
Núria Pujol Giménez (Researcher)
Alfonso Rodríguez Martínez (Researcher)
Silvia Oller Canet (PhD Student)
Eva Luque Asín (Research Assistant)
Main Publications
• Davey CG, Breakspear M, Pujol J, Harrison BJ. A Brain Model of Disturbed Self-Appraisal in Depression. Am J Psychiatry 2017; 174(9): 895-903. IF 14.176. D1.
• Radua J, Grunze H, Amann BL. Meta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder. Psychother Psychosom 2017; 86(2): 90-98. IF 8.964. D1.
• Mortamais M, Pujol J, van Drooge BL, Macià D, Martínez-Vilavella G, Reynes C, Sabatier R, Rivas I, Grimalt J, Forns J, Álvarez-Pedrerol M, Querol X, Sunyer J. Effect of exposure to polycyclic aromatic hydrocarbons on basal ganglia and attention-deficit hyperactivity disorder symptoms in primary school children. Environ Int 2017; 105: 12-19. IF 7.088. D1.
• Sunyer J, Suades-González E, García-Esteban R, Rivas I, Pujol J, Álvarez-Pedrerol M, Forns J, Querol X, Basagaña X. Traffic-related air pollution and attention in primary school children: short-term association. Epidemiology 2017; 28(2): 181-189. IF 5.986. D1.
• Amann BL, Radua J, Wunsch C, König B, Simhandl C. Psychiatric and physical comorbidities and their impact on the course of bipolar disorder: A prospective, naturalistic 4-year follow-up study. Bipolar Disord 2017; 19(3): 225-234. IF 4.531. Q1.
• Torres I, Solé B, Corrales M, Jiménez E, Rotger S, Serra-Pla JF, Forcada I, Richarte V, Mora E, Jacas C, Gómez N, Mur M, Colom F, Vieta E, Casas M, Martínez-Aran A, Goikolea JM, Ramos-Quiroga JA. Are patients with bipolar disorder and comorbid attention-deficit hyperactivity disorder more neurocognitively impaired?. Bipolar Disord 2017; 19(8): 637-650. IF 4.531. Q1.
• Murru A, Torra M, Callari A, Pacchiarotti I, Romero S, González de la Presa B, Varo C, Goikolea JM, Pérez V, Vieta E, Colom F. A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder. Eur Neuropsychopharmacol 2017; 27(8): 744-750. IF 4.239. Q1.
• Pousa E, Ochoa S, Cobo J, Nieto L, Usall J, González B, García-Ribera C, Pérez V, Ruiz-Ripoll I, Insight Barcelona Research Group. A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors. Schizophr Res 2017; 189: 61-68. IF 3.986. Q1.
• Quintana P, Ventura-Vilamala M, Grifell M, Palma A, Galindo L, Fornís I, Gil-Lladanosa C, Carbón X, Caudevilla F, Farré M, Torrens M. The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin. Int J Drug Policy 2017; 40: 78-83. IF 3.479. Q1.
• Hidalgo-Mazzei D, Reinares M, Mateu A, Juruena MF, Young AH, Pérez V, Vieta E, Colom F. Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder?. J Affect Disorders 2017; 223: 10-16. IF 3.432. Q1.
Ongoing Research Projects
• Estimulación cerebral profunda en el cíngulo subgeniculado y el núcleo accumbens como tratamiento a pacientes con anorexia nerviosa crónica, severa y refractaria
- Fondo de Investigación Sanitaria. ISCIII (PI16/00382)
- From 2017 to 2019
- Principal investigator: Pérez Sola, Víctor
• Single-blind, Randomized Controlled Comparison of EMDR Versus Supportive Therapy in Affective Relapse Prevention in Bipolar Patients With a History of Trauma
- Brain & Behavior Research Foundation (24397)
- From 2017 to 2019
- Principal investigator: Amann, Benedikt Lorenz
• Estudio del estado de activación del factor Nrf2 en cultivo primario de pro-neuronas a partir de epitelio olfatorio en el Trastorno Depresivo Mayor
- Fondo de Investigación Sanitaria. ISCIII (PI15/00398)
- From 2016 to 2018
- Principal investigator: Álvarez López, Pilar
• Estudio simple ciego, randomizado y controlado para comparar la eficacia de EMDR vs terapia de apoyo en la prevención de recaídas afectivas en bipolares con evento traumático previo
- Fondo de Investigación Sanitaria. ISCIII (PI15/02242)
- From 2016 to 2018
- Principal investigator: Amann, Benedikt Lorenz
• Mejorando la relación terapéutica en los cuidados enfermeros a través de la evidencia. Una investigación-acción participativa en unidades de agudos de psiquiatría
- Col·legi Oficial d'Infermeria de Barcelona (PR-1915/14)
- From 2015 to 2017
- Principal investigator: Moreno Poyato, Antonio Rafael
• Eficacia del programa online iFightDepression para el tratamiento de la depresión leve y moderada
- Fondo de Investigación Sanitaria. ISCIII (PI13/00171)
- From 2014 to 2018
- Principal investigator: Pérez Sola, Víctor
• SIMPLeBand: Monitorización pasiva de signos en pacientes con trastorno bipolar en estadios avanzados mediante smartbands para la prevención de recaídas
- Fondo de Investigación Sanitaria. ISCIII (PI15/00588)
- From 2016 to 2018
- Principal investigator: Colom Victoriano, Francesc
Participation in Research Networks
• CIBERSAM – Centro de Investigación Biomédica en Red de Salud Mental
- Fondo de Investigación Sanitaria. Subprograma CIBER (CB07/09/0010)
- Principal investigator Pérez Sola, Víctor
Group’s Recognitions
• Officially recognised as a consolidated research group by the Generalitat de Catalunya: Unitat de Recerca en Fisiopatologia Òssia i Articular (2017-2019)
- Agència de Gestió d’Ajuts Universitaris i de Recerca (SGR 134)
- Principal investigator: Colom Victoriano, Francesc
Clinical Trials Signed in 2017
• Single-blind, Randomized Controlled Comparison of EMDR Versus Supportive Therapy in Affective Relapse Prevention in Bipolar Patients With a History of Trauma
- Brain & Behavior Research Foundation (24397)
- From 2017 to 2019
- Principal investigator: Amann, Benedikt Lorenz
Theses
• Novo P. Desensibilización y reprocesamiento por movimiento ocular; ensayo piloto en pacientes bipolares, hipótesis de funcionamiento y revisión sistemática. Autonomous University of Barcelona
- Director: Amann, Benedikt Lorenz
- Date of defense: 17/03/2017
• Galindo L. Neurological soft signs, temperament and schizotypy in patients with schizophrenia and unaffected relatives: an FMRI study. Autonomous University of Barcelona
- Director: Bergé, D; Pérez Solà, Víctor
- Date of defense: 24/04/2017
• Tejedor RM. Conciencia y aceptación en salud mental. Autonomous University of Barcelona
- Director: Víctor Pérez Solà; Soler, J
- Date of defense: 06/09/2017
• Cavero M. Impacto de la guía clínica de la depresión informatizada de Cataluña en el diagnóstico y el tratamiento de la depresión en atención primaria: estudio controlado del efecto de un proceso de implementación. Autonomous University of Barcelona
- Director: Pérez Solà, Víctor
- Date of defense: 15/09/2017
• Oller S. Receptor 5-HT1A i ISRS: Escurçament de la resposta antidepressiva. Autonomous University of Barcelona
- Director: Pérez Solà, Víctor; Portella, MJ
- Date of defense: 15/12/2017
C/ Doctor Aiguader, 88
08003 Barcelona
(+34) 93 316 04 00
info@imim.es